+DayWeekMonth−
Monday · Nov 9, 2026 · Health Digest · science

Trial finds stopping statins was noninferior to continuing them in older adults without heart disease

During the first two years, 10.7% of participants who stopped statins and 8.2% of those who continued had a nonfatal heart attack, nonfatal ischemic stroke or died, the American Heart Association said. Over the full follow-up, the figures were 12.7% and 9.2%. The trial ran at 24 centers in Switzerland, France and the Netherlands, and found no difference between the groups in pain, quality of life, fall risk or muscle weakness, according to the AHA.

Lead investigator Nicolas Rodondi of the University of Bern estimated that one additional major cardiovascular event or death would occur over two years for every 40 people who stopped statins, and said this needs further study, the AHA reported. TCTMD and Healio reported that the results are meant to inform shared decision-making between patients and doctors.

Why it matters: The AHA said 80% of general practitioners from 30 countries already advise stopping statins in people 80 or older without cardiovascular disease who have side effects or frailty. The trial tested that practice in a randomized study.

References

  1. Late-breaking trials challenge conventional treatments to cardiovascular disease
    American Heart Association · sessions.hub.heart.org · 2026-11-09
  2. Study informs statin discontinuation in older adults without CVD
    Healio · healio.com · 2026-11-09
  3. Elderly Patients on Statins for Primary Prevention Can Stop, but It's Not Risk Free: STREAM
    TCTMD · tctmd.com · 2026-11-09